Tumor Infiltrating Lymphocytes Biobank

Overview

About this study

The purpose of this repository is to provide clinical samples to support basic science and translational research efforts to improve TIL therapy. The process of isolating TILs from tumor tissue involves processing of fresh tissue from surgical specimens, and this protocol would establish a novel collection for tissue that would not otherwise be available through current tissue banks. 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • All patients with solid tumor metastases will be eligible and considered for inclusion.

Exclusion Criteria: 

  • None.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/17/2024. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Arkadiusz Dudek, M.D., Ph.D.

Contact us for the latest status

Contact information:

Alisha Birgin M.S.

(507) 266-9955

Birgin.Alisha@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20580464

Mayo Clinic Footer